Investing.com - Apyx Medical (NASDAQ: APYX) reported second quarter EPS of $-0.03, $0.04 better than the analyst estimate of $-0.07. Revenue for the quarter came in at $13.57M versus the consensus estimate of $14.33M.
Apyx Medical's stock price closed at $4.21. It is down -21.46% in the last 3 months and down -59.05% in the last 12 months.
Apyx Medical saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Apyx Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Apyx Medical's Financial Health score is "fair performance".
Check out Apyx Medical's recent earnings performance, and Apyx Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar